Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Vancomycin dosing for severe methicillin-resistant Staphylococcus aureus infections: a pilot study

EF 2021-22

Résumé
Methicillin-resistant Staphylococcus aureus (MRSA) is a resistant type of bacteria that causes serious infections of the blood, brain, heart valve, lung, bone or joint. Intravenous vancomycin is a first line antibiotic used to treat these infections. Vancomycin requires monitoring of the drug level in the blood to adjust the dose. Based on the newest guideline, vancomycin should be dosed based on a model of the drug level over time, which is called area under the curve (AUC). The AUC target is 400. Dosing based on AUC is difficult, because it requires complex calculations using an expensive software. A simpler way is to target a trough level of 10 to 15mg/L when the drug level is at its lowest. We aim to compare these two different dosing strategies in patients with serious MRSA infections in terms of clinical cure in a large randomized trial. The study will include patients admitted to three hospitals in Hamilton, Ontario with MRSA infection of the blood, brain, heart valve, lung, bone, joint or a deep-seated abscess who require vancomycin treatment. Patients will be randomized to either a dosing strategy based on the trough level or one based on the AUC. These patients will be followed for 3 months. If the clinical cure rate is similar between the two groups at the end of follow-up, then the simpler trough-based strategy would be preferred, because it is easier and cheaper to adopt in hospitals. For my thesis, we will be conducting a pilot study, which is a smaller version of the planned trial. In this study, we will determine the number of patients being recruited over time as well as proportion of patients who were given the correct dose and completed follow-up to ensure that it would be feasible to carry out the larger trial.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466572
Name
Bai Anthony D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Vancomycin dosing for severe methicillin-resistant Staphylococcus aureus infections: a pilot study
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Therapy; Clinical Effectiveness; Drug Safety; Methicillin-Resistant Staphylococcus Aureus (Mrsa); Pharmacokinetics; Vancomycin
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a resistant type of bacteria that causes serious infections of the blood, brain, heart valve, lung, bone or joint. Intravenous vancomycin is a first line antibiotic used to treat these infections. Vancomycin requires monitoring of the drug level in the blood to adjust the dose. Based on the newest guideline, vancomycin should be dosed based on a model of the drug level over time, which is called area under the curve (AUC). The AUC target is 400. Dosing based on AUC is difficult, because it requires complex calculations using an expensive software. A simpler way is to target a trough level of 10 to 15mg/L when the drug level is at its lowest. We aim to compare these two different dosing strategies in patients with serious MRSA infections in terms of clinical cure in a large randomized trial. The study will include patients admitted to three hospitals in Hamilton, Ontario with MRSA infection of the blood, brain, heart valve, lung, bone, joint or a deep-seated abscess who require vancomycin treatment. Patients will be randomized to either a dosing strategy based on the trough level or one based on the AUC. These patients will be followed for 3 months. If the clinical cure rate is similar between the two groups at the end of follow-up, then the simpler trough-based strategy would be preferred, because it is easier and cheaper to adopt in hospitals. For my thesis, we will be conducting a pilot study, which is a smaller version of the planned trial. In this study, we will determine the number of patients being recruited over time as well as proportion of patients who were given the correct dose and completed follow-up to ensure that it would be feasible to carry out the larger trial.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bai, Anthony D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~